Could 5 days of antibiotics cut infections after pancreatic surgery?
NCT ID NCT06123169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two antibiotic strategies in 326 adults undergoing pancreatic surgery who had a bile duct stent placed before surgery. One group gets antibiotics only during surgery, the other gets them for 5 days after. The goal is to see if the longer course reduces surgical site infections, including pancreatic leaks. The trial is not yet recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Piperacillin-tazobactam (an antibiotic)
- What this could lead to
- If successful, this could establish a standard antibiotic regimen to prevent serious infections after pancreatic surgery in patients with a prior bile duct stent.
- What could go wrong
- This is a Phase 3 trial, but it has not yet started recruiting. The benefit may be small, and antibiotics carry risks like allergic reactions or drug-resistant infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBIOTHERAPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de ROUEN
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tailored nutrition after pancreatic surgery could speed recovery
- Hidden artery problem may raise surgery risks for pancreatic cancer patients
- No-Tube approach tested for pancreatic surgery recovery
- Radiation before pancreatic surgery may prevent dangerous leaks
- Pain-block study for major pancreas surgery fizzles out
- Robot vs. doctor: can a machine outperform anesthesiologists in fluid management?